Zfp281 and Zfp148 control CD4 + T cell thymic development and T H 2 functions
Science Immunology · 24.11.2023 · 8 (89)
DOI: 10.1126/sciimmunol.adi9066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 24.11.2023. Verfasst von Laura B Chopp und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Transcription Factors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
How CD4 + lineage gene expression is initiated in differentiating thymocytes remains poorly understood. Here, we show that the paralog transcription factors Zfp281 and Zfp148 control both this process and cytokine expression by T helper cell type 2 (T H 2) effector cells. Genetic, single-cell, and spatial transcriptomic analyses showed that these factors promote the intrathymic CD4 + T cell differentiation of class II major histocompatibility complex (MHC II)–restricted thymocytes, including expression of the CD4 + lineage–committing factor Thpok. In peripheral T cells, Zfp281 and Zfp148 promoted chromatin opening at and expression of T H 2 cytokine genes but not of the T H 2 lineage–determining transcription factor Gata3. We found that Zfp281 interacts with Gata3 and is recruited to Gata3 genomic binding sites at loci encoding Thpok and T H 2 cytokines. Thus, Zfp148 and Zfp281 collaborate with Gata3 to promote CD4 + T cell development and T H 2 cell responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Immunology Graduate Group, University of Pennsylvania Medical School, Philadelphia, PA 19104, USA.
- Molecular and Cellular Immunoregulation Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Single Cell Analysis Facility, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
- University of Maryland Medical School, Baltimore, MD 21201, USA.
ORCID-Profile: Laura B Chopp, Xiaoliang Zhu, Parimal Kumar, Kelly Z Young, Shil Patel, Mariah Balmaceno-Criss, Melanie S Vacchio, Michael M Wang, Ferenc Livak, Juanita L Merchant, Lie Wang, Michael C Kelly, Rémy Bosselut
Förderung
- Intramural NIH HHS
- NCI NIH HHS
Zitieren
APA
Chopp, L. B., Zhu, X., Gao, Y., Nie, J., Singh, J., Kumar, P., Young, K. Z., Patel, S., Li, C., Balmaceno-Criss, M., Vacchio, M. S., Wang, M. M., Livak, F., Merchant, J. L., Wang, L., Kelly, M. C., Zhu, J., & Bosselut, R. (2023). Zfp281 and Zfp148 control CD4 + T cell thymic development and T H 2 functions. Science Immunology, 8(89). https://doi.org/10.1126/sciimmunol.adi9066
Vancouver
Chopp LB, Zhu X, Gao Y, Nie J, Singh J, Kumar P, et al. Zfp281 and Zfp148 control CD4 + T cell thymic development and T H 2 functions. Science Immunology. 2023;8(89). doi:10.1126/sciimmunol.adi9066
BibTeX
@article{Chopp2023,
author = {Chopp, Laura B and Zhu, Xiaoliang and Gao, Yayi and Nie, Jia and Singh, Jatinder and Kumar, Parimal and Young, Kelly Z and Patel, Shil and Li, Caiyi and Balmaceno-Criss, Mariah and Vacchio, Melanie S and Wang, Michael M and Livak, Ferenc and Merchant, Juanita L and Wang, Lie and Kelly, Michael C and Zhu, Jinfang and Bosselut, Rémy},
title = {Zfp281 and Zfp148 control CD4 + T cell thymic development and T H 2 functions},
journal = {Science Immunology},
year = {2023},
volume = {8},
number = {89},
doi = {10.1126/sciimmunol.adi9066}
}
EUVIMED